W. Holtkamp

421 total citations
24 papers, 261 citations indexed

About

W. Holtkamp is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, W. Holtkamp has authored 24 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Cancer Research. Recurrent topics in W. Holtkamp's work include Pituitary Gland Disorders and Treatments (7 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Cancer Treatment and Pharmacology (5 papers). W. Holtkamp is often cited by papers focused on Pituitary Gland Disorders and Treatments (7 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Cancer Treatment and Pharmacology (5 papers). W. Holtkamp collaborates with scholars based in Germany. W. Holtkamp's co-authors include H. E. Reis, H. Rauschecker, Gerd Nagel, D. von Heyden, Wolfgang Müller, R. Becher, M. Nagel‐Hiemke, S. Seeber, Bertram Opalka and O. Kloke and has published in prestigious journals such as International Journal of Cancer, British Journal of Haematology and Cancer Treatment Reviews.

In The Last Decade

W. Holtkamp

21 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Holtkamp Germany	8	89	54	53	51	50	24	261
Joseph Corkery United States	8	74 0.8×	33 0.6×	63 1.2×	17 0.3×	91 1.8×	8	331
Kazutoshi Mizunashi Japan	9	64 0.7×	46 0.9×	165 3.1×	38 0.7×	81 1.6×	24	390
H. Flax United Kingdom	10	132 1.5×	53 1.0×	117 2.2×	60 1.2×	37 0.7×	20	342
D E Carey United States	6	51 0.6×	22 0.4×	61 1.2×	41 0.8×	45 0.9×	9	334
S. A. Gruber United States	12	89 1.0×	41 0.8×	144 2.7×	13 0.3×	55 1.1×	24	379
Gillian R. Milner United Kingdom	12	32 0.4×	79 1.5×	55 1.0×	60 1.2×	171 3.4×	21	487
Tshela E. Mason United States	10	148 1.7×	50 0.9×	73 1.4×	38 0.7×	73 1.5×	20	324
P Y Chong Singapore	9	112 1.3×	23 0.4×	54 1.0×	34 0.7×	125 2.5×	14	331
Ferhunde Dizdaroğlu Türkiye	11	90 1.0×	29 0.5×	155 2.9×	64 1.3×	50 1.0×	18	309
Izabella Czajka-Oraniec Poland	8	130 1.5×	88 1.6×	45 0.8×	104 2.0×	46 0.9×	17	352

Countries citing papers authored by W. Holtkamp

Since Specialization

Citations

This map shows the geographic impact of W. Holtkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Holtkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Holtkamp more than expected).

Fields of papers citing papers by W. Holtkamp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Holtkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Holtkamp. The network helps show where W. Holtkamp may publish in the future.

Co-authorship network of co-authors of W. Holtkamp

This figure shows the co-authorship network connecting the top 25 collaborators of W. Holtkamp. A scholar is included among the top collaborators of W. Holtkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Holtkamp. W. Holtkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Holtkamp, W., et al.. (2008). Ultraschallgesteuerte Feinnadelpunktion: Grenzen der Methode im Abdomen und Retroperitonealraum. DMW - Deutsche Medizinische Wochenschrift. 115(21). 809–812.

Holtkamp, W., et al.. (2008). Bedeutung der Prolactin-Bestimmung bei metastasiertem Mammakarzinom. DMW - Deutsche Medizinische Wochenschrift. 109(2). 62–63.

Holtkamp, W.. (2001). Perkutane minimalinvasive Entfernung von Lebertumoren. Oncology Research and Treatment. 24(1). 59–64. 1 indexed citations

Holtkamp, W. & Wolfgang Müller. (2000). Sonographisch gesteuerte perkutane Hochfrequenzthermotherapie von Lebertumoren mit perfundierten Nadelelektroden. Zeitschrift für Gastroenterologie. 38(3). 221–227. 11 indexed citations

Holtkamp, W., et al.. (1995). Serum Interleukin-6 Is Related to Disease Activity but Not Disease Specificity in Inflammatory Bowel Disease. Journal of Clinical Gastroenterology. 20(2). 123–126. 53 indexed citations

Holtkamp, W., et al.. (1994). Papillomatosis of the bile ducts: papilloma-carcinoma sequence.. PubMed. 89(12). 2253–5. 28 indexed citations

Holtkamp, W., et al.. (1993). Zinc supplementation stimulates tetanus antibody formation and soluble interleukin-2 receptor levels in chronic hemodialysis patients. Journal of Molecular Medicine. 71(7). 537–41. 10 indexed citations

Kloke, O., M. Nagel‐Hiemke, R. Becher, et al.. (1992). Combination therapy with interferon alpha‐2b plus low‐dose interferon gamma in pretreated patients with Ph‐positive chronic myelogenous leukaemia. British Journal of Haematology. 81(4). 516–519. 29 indexed citations

Holtkamp, W., et al.. (1991). Einfluß einer Zinksubstitution auf Lymphozytensubsets und zelluläre Immunfunktionen bei Hämodialysepatienten. Journal of Molecular Medicine. 69(9). 392–396. 6 indexed citations

10.

Holtkamp, W., et al.. (1990). Erniedrigte Plasmazinkspiegel beim metastasierten Mammakarzinom. Oncology Research and Treatment. 13(3). 207–209. 6 indexed citations

11.

Holtkamp, W., et al.. (1989). [Gaucher disease and pregnancy].. PubMed. 192(6). 278–81. 3 indexed citations

12.

Holtkamp, W., D. Emrich, Michael Kneba, et al.. (1988). High-Dose Epirubicin + Cyclophosphamide (HD-EC) in Metastatic Breast Cancer: A Dose-Finding Study. Oncology Research and Treatment. 11(6). 287–288. 3 indexed citations

13.

Emrich, D., W. Holtkamp, Michael Kneba, et al.. (1988). High-Dose Epirubicin + Cyclophosphamide (HD-EC) in Metastatic Breast Cancer: Preliminary Data of a Phase-II Study. Oncology Research and Treatment. 11(6). 289–291. 1 indexed citations

14.

Holtkamp, W., et al.. (1988). Bromokriptin beim chemotherapieresistenten, metastasierten Mammakarzinom. Oncology Research and Treatment. 11(3). 121–127. 12 indexed citations

15.

Holtkamp, W., et al.. (1988). Pathophysiologie der Hyperprolaktinämie beim Mammakarzinom. Oncology Research and Treatment. 11(2). 86–103. 1 indexed citations

16.

Holtkamp, W., et al.. (1986). Mastectomy stimulates prolactin release in breast cancer patients. Journal of Cancer Research and Clinical Oncology. 111(S1). S79–S79. 9 indexed citations

17.

Holtkamp, W. & Georg Nagel. (1986). Metergolin beim hyperprolaktinämischen Mammakarzinom: Eine Phase-II-Studie. Oncology Research and Treatment. 9(5). 245–248. 2 indexed citations

18.

Holtkamp, W., et al.. (1986). Significance of prolactin (PRL) receptor determination in breast cancer. Journal of Cancer Research and Clinical Oncology. 111(S1). S12–S12. 1 indexed citations

19.

Holtkamp, W., et al.. (1984). Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer. International Journal of Cancer. 34(3). 323–328. 70 indexed citations

20.

Holtkamp, W., et al.. (1983). [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].. PubMed. 113(41). 1513–20. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact